WednesdayJan 11, 2023 9:56 am

QualityStocksNewsBreaks — MetAlert Inc. (MLRT), TrakTec Sign Heads of Terms Agreement for Upcoming Acquisition

MetAlert (OTC: MLRT), a pioneer in location-sensitive, health-monitoring devices and wearable technology products for remote patient monitoring, signed a Heads of Terms agreement with TrakTec outlining details about the previously announced acquisition. The agreement noted that MLRT would acquire the location-awareness technology company in a cash and stock deal worth $4.5 million. The agreement also notes that the acquisition should be closed on or before March 17, 2023, and will include TrakTec’s active paying subscriber base, police department contracts, commercial ready tracking products, and backend platform and mobile app. In addition, the agreement noted that key hires would include board…

Continue Reading

WednesdayJan 11, 2023 9:00 am

Sharing Services Global Corp. (SHRG) Focuses on Increasing Shareholder Value in Industry Looking at Billion-Dollar Growth

Report notes that the global direct-selling establishments market is expected to close the year out at a compound annual growth rate (“CAGR”) of 3.8% The need for additional income opportunities has been a driving factor in the direct-selling establishments market SHRG is committed to stay ahead of marketplace trends, fulfill needs, create sustainable enterprise growth and consistently increase shareholder value In a market forecast to grow an estimated $20 billion this year alone (https://ibn.fm/tijsB), Sharing Services Global (OTCQB: SHRG) distinguishes itself in the direct-sales space by focusing on a mission to increase shareholder value by adhering to standards of excellence…

Continue Reading

WednesdayJan 11, 2023 8:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Adds to its Existing Suite of Global Patents with First Granted Patent in Canada

Lexaria has announced patent #3,093,414, its first patent in Canada, its 28th granted patent worldwide, and the first patent from its sixth patent family This patent joins the ranks of previously issued patents in Australia, India, Japan, and the EU, even as similar patent applications for skin-based delivery of patented DehydraTECH formulations remain pending in many countries In Lexaria’s 2018 study, DehydraTECH-processed CBD demonstrated almost a 1,900% increase in CBD permeability through human skin compared to a control formulation that was devoid of any commercial penetration enhancers This patent inches Lexaria closer to taking advantage of the cosmeceuticals market, projected…

Continue Reading

TuesdayJan 10, 2023 3:01 pm

QualityStocksNewsBreaks – CubCrafters Inc. Merging High Performance, Latest Technology to Bring Unique Perspective to Access the World

CubCrafters is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “CubCrafters President and CEO Patrick Horgan recently provided an update, announcing in a Bell2Bell podcast that the U.S. Securities and Exchange Commission (‘SEC’) has qualified the company’s Reg A+ filing, clearing the way for investors to come onboard… Horgan said that the company has booked orders already awaiting fulfillment for the next two years of CubCrafters’ production schedule, and a large part of the reason for turning to public funding is to help the company grow sufficiently that it can reduce customers’ wait times,…

Continue Reading

TuesdayJan 10, 2023 1:49 pm

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Featured on ‘Gametime with Sequire’

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, was featured in a recent interview with Sequire Spotlight. In the program, MetAlert’s CEO Patrick Bertagna joined Host Carmel Fisher to discuss the company’s business model and goals heading into the near future. “We’re a medical device/technologies company. We cater to a specific segment of the population – people with cognitive memory disorders such as Alzheimer’s, dementia, autism, traumatic brain injury,” Bertagna said. “And most of these people can’t use conventional type of technologies. So, we’ve developed a suite of products and…

Continue Reading

TuesdayJan 10, 2023 12:34 pm

QualityStocksNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Inks Deal to Acquire South America-Based Cybersecurity Company

CISO Global (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider formally known as Cerberus Sentinel, has signed a definitive agreement to acquire RAN Security, a cybersecurity company headquartered in Buenos Aires, Argentina, and with offices in Chile, Peru, Bolivia, and Paraguay. According to the agreement, RAN Security will become a wholly owned subsidiary of Cerberus Sentinel. CISO Global anticipates the transaction will be finalized later this year following customary closing conditions and applicable regulatory approvals. RAN Security offers secured managed services to organizations across South America and is part of a growing network of companies acquired…

Continue Reading

TuesdayJan 10, 2023 12:25 pm

QualityStocksNewsBreaks – Vision Energy Corp. (VENG) Incorporates Dutch Subsidiaries

Vision Energy (OTCQB: VENG), a forward-looking energy company developing carbon reduced solutions for the commercial, industrial and transportation sector, has incorporated new Dutch subsidiaries. These incorporations are designed to accommodate strategic initiatives for prospective partners, operators and launching customers for VENG’s integrated Green Energy Hub development in North Sea Port of Vlissingen, the Netherlands. According to the announcement, Vision Energy incorporated Vision Hydrogen BV as a project development company to develop, own and operate its planned Ammonia Cracking Facility. The facility will be used for back-cracking imported green ammonia to hydrogen gas as a service and will be combined with the…

Continue Reading

TuesdayJan 10, 2023 12:06 pm

QualityStocksNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Secures VB100 Certification for Antivirus Product

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced that its Data443(R) Antivirus Protection Manager(TM) has received VB100 certification. The certification is administered by Virus Bulletin, an independent organization that has tested antivirus products for more than 25 years. Joining leading organizations such as SentinelOne (NYSE: S), Fortinet (NASDAQ: FTNT), Avast Intego and Tacyon, Data443’s antivirus product is available for Microsoft Windows via desktops, laptops, virtual desktops, database engines, and Azure/AWS/GCP, along with hybrid cloud platforms and standard compute servers. “At Data443, we make every effort to help protect customers from the…

Continue Reading

TuesdayJan 10, 2023 12:00 pm

Aditxt, Inc. (NASDAQ: ADTX) Bolsters Goal to Conduct First-In-Human Clinical Trial Evaluating ADI(TM) Tech with Formation of Adimune, Inc. Subsidiary; Appoints Industry Veteran as Subsidiary Chairman and CEO

Aditxt recently announced the formation of a U.S.-based wholly owned subsidiary, Adimune, Inc., and appointed Joachim-Friedrich Kapp, M.D., Ph.D., a 30-year veteran of the pharmaceutical industry, as its Chairman and CEO Dr. Kapp will be tasked with leading and developing the Apoptotic DNA Immunotherapy(TM) (“ADI(TM)”) technology toward clinical trials Aditxt also plans to submit a Clinical Trial Application (“CTA”) for immunotherapeutic technology drug candidate ADI(TM)-100, seeking approval for Adimune(TM) to conduct the first-in-human study in psoriasis patients, beginning in the second half of 2023 ADI(TM) is a nucleic acid-based technology platform that utilizes a novel antigen-specific approach to induce immune…

Continue Reading

TuesdayJan 10, 2023 11:46 am

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Releases Shareholder Letter Outlining 2022 Updates, 2023 Milestone Goals

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has provided key updates and milestone goals in a shareholder letter; the letter is from QSAM Biosciences executive chair and cofounder C. Richard Piazza and CEO and cofounder Douglas Baum. The letter noted that QSAM is developing its lead therapeutic radiopharmaceutical drug candidate, CycloSam, to treat cancer that has either originated in the bone or has metastasized to the bone from the breast, prostate, lung or other organs. During 2022, CycloSam received rare pediatric disease designation for the…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered